Harvard Bioscience Inc (NASDAQ:HBIO) is reporting third quarter earnings results on Thursday 25th October 2018, .
The consensus estimates from Thomson Reuters are income of $ 0.04 per share from $ 29.13 million in revenue.
The same period from last year, HBIO reportedly had income of $ 0.03 per share on $ 25.05 million in revenue.
For the full year, analysts predict revenues of $ 120.86 million, while looking forward to income of $ 0.21 per share.
About Harvard Bioscience Inc
|% Change from 52 Week Low|
|% Change from 52 Week High|